iNet Login|
United States
Pharma & Biopharma Manufacturing & Testing Services
Contact Us 1.800.756.5658

Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry


  • Merck KGaA to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx. $17 billion (€13.1 billion)
  • Acquisition expands EMD Millipore’s global reach, increasing the company’s presence in North America and adding exposure to fast-growing Asian markets
  • Customers benefit from broader offering of complementary products and capabilities and leading e-commerce platform in the industry
  • Merck KGaA plans to maintain significant presence in St. Louis, MO, and Billerica, MA
  • Life Science contribution to Merck KGaA earnings more than doubles
  • Transaction expected to be immediately accretive to EPS pre and EBITDA margin
  • Merck KGaA to host media conference call today at 8:00 AM EDT / 2:00 PM CET

Darmstadt, Germany and St. Louis, MO, September 22, 2014 – Merck KGaA, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life science sectors, and Sigma-Aldrich today announced that they have entered into a definitive agreement under which Merck KGaA, Darmstadt, Germany, will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry.

Apps, Tools, Newsletters & More...
  Find the latest scientific resources from Sigma-Aldrich.

Copyright © 2017 Sigma-Aldrich Co. LLC.  All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission.  Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich Co. LLC. Sigma-Aldrich Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany  Terms | Privacy